Upside For Flexion Therapeutics Depends On How Well It Can Commercialize ZILRETTA In 2020 [Seeking Alpha]
Flexion Therapeutics, Inc. (FLXN)
Last flexion therapeutics, inc. earnings: 11/7 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.flexiontherapeutics.com
Company Research
Source: Seeking Alpha
Summary ZILRETTA sales appear to be plateauing given Q4 2020 revenue. ZILRETTA's label change on its face doesn't appear very helpful, but may drive sales based on deeper discussion of published data. Large market gives upside, but will require FLXN to find ways to grow market share in a highly competitive market. If FLXN can hit 2020 revenue guidance, company is undervalued given recent decreases in stock price. Flexion Therapeutics (NASDAQ: catalyst calendar on Ampbioresearch.com web site corporate slide deck ZILRETTA/knee osteoarthritis In our view, for FLXN at this point, it comes down to how well the company commercializes ZILRETTA in the osteoarthritis knee pain market. ZILRETTA is a long-acting extended release therapy that was first approved by the FDA in October 2017 for the treatment of knee pain associated with osteoarthritis. An sNDA (updated label) was approved for ZILRETTA late last year related to repeat administration. With over 6 million steroid injections annually to
Show less
Read more
Impact Snapshot
Event Time:
FLXN
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
FLXN alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
FLXN alerts
High impacting Flexion Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics